Sermorelin 10mg Vial
$120.00
Sermorelin 10 mL Vial
The Science, Simplified: Sermorelin is a synthetic 29-amino acid peptide corresponding to the active N-terminal fragment of growth hormone-releasing hormone (GHRH 1-29), used as a GHRH-analogue research tool.
Product Specifications – Sermorelin 10 mL Vial (10 mg)
- Total Sermorelin: 10 mg
- Volume: 10 mL vial
- Concentration: 1 mg/mL
- Purity: Research-grade, third-party tested (COA available)
- Format: Ready-to-use liquid vial
Key Research Focus: Examined in laboratory GH-axis models studying native-length GHRH fragment receptor activation and pulsatile GH-release signaling in preclinical systems.
Physical Form & Solubility:
- Appearance: Clear to slightly opalescent liquid
- Solubility: Already in aqueous solution (acetate salt form for optimal solubility and stability). Highly soluble; no reconstitution required.
Stability & Handling Notes:
- Refrigerated at 36-46°F. Practical shelf life is 16-20 weeks when protected from light and handled with aseptic technique.
- Do not freeze. Avoid prolonged room-temperature exposure.
- Discard after 20 weeks or if the solution becomes cloudy, discolored, or shows particulate matter.
- Protect from light and moisture at all times.
- For lyophilized orders please contact us (minimum order required)
https://www.palmbeach-vitality.com
Sermorelin 10 mg / 10 mL (1 mg/mL) research vial from Palm Beach Vitality. Third-party tested with COA. Laboratory research use only.
How Labs Use This Format: Pipette at 1 mg/mL from this ready-to-use liquid vial for single-compound GHRH 1-29 pathway work. Related GHRH analog pens or vials (CJC, Tesamorelin) may be available when alternate analogues are needed.
Documentation Trail: Third-party testing and lot-matched COA from Palm Beach Vitality support laboratory procurement records. Cold-pack shipping on qualifying orders.
Sermorelin research vial at 10 mg in 10 mL (1 mg/mL) for laboratory GHRH-fragment protocols. Ready-to-use liquid with COA; research use only.
Sermorelin Research Studies
Selected English-language peer-reviewed references for laboratory research context. Links open publisher or PubMed/PMC records.
- Sermorelin: a better approach to management of adult-onset growth hormone insufficiency?PubMed 18046908
- Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiencyPubMed 18031173
- A potentially effective drug for patients with recurrent glioma: sermorelinPubMed 33842627
- Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunctionPubMed 10905389
- Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapyPubMed 8772599
